Public Alert No. 030/2026
Alert on the withdrawal of Levamisole-containing medicines as endorsed by the Italian Medicines Agency (AIFA) over serious neurological risks
#NAFDACAlerts
https://t.co/hdq5i5o156
NAFDAC Convenes Stakeholders’ Engagement to Showcase Regulatory Transformation and Strengthen Nigeria’s Commitment to the African Medicines Agency
NAFDAC, in collaboration with World Bank, the Bank of Industry, and the Federal Ministry of Health and Social Welfare, convened a One-Day Stakeholders’ Engagement on Monday, 5 May 2026, at the Abuja Intercontinental Hotel. The event, themed “Nigeria’s Leadership in Strengthening Medicines Regulation and Public Health in Africa,” brought together key national, regional, and international stakeholders to advance dialogue on regulatory excellence and continental collaboration.
The Director-General of NAFDAC, Prof. Mojisola Adeyeye, highlighted NAFDAC’s regulatory transformation in recent years, driven by strategic reforms, digital innovation, strengthened enforcement, and alignment with international best practices. These efforts have enhanced transparency, efficiency, and turnaround time for regulatory processes, while reinforcing the Agency’s capacity to safeguard public health and support national development. Nigeria’s growing regulatory maturity continues to position the country as a leading authority in medicines regulation across Africa.
A central focus of the engagement was Nigeria’s commitment to the African Medicines Agency (AMA), an African Union initiative aimed at harmonising medicines regulation, improving access to quality-assured medical products, and strengthening health systems across the continent. Stakeholders emphasised the importance of regional cooperation in pharmacovigilance, manufacturing oversight, and the fight against substandard and falsified medical products.
The forum also provided a platform to deepen partnerships with development agencies, the private sector, academia, and international organisations, while exploring investment opportunities in local pharmaceutical manufacturing and regulatory capacity development. Participants reaffirmed the need for sustained collaboration to drive innovation, strengthen systems, and enhance access to safe, effective, and quality medicines.
NAFDAC reiterated its commitment to advancing regulatory excellence, promoting public health, and supporting Nigeria’s leadership role in Africa’s health security agenda. The Agency emphasised that the outcomes of the engagement will contribute to strengthening stakeholder confidence, fostering investment, and accelerating the implementation of a robust, modern regulatory framework aligned with continental and global standards.
🤝 Africa CDC and AMA (@AU_AMA_) are joining forces to drive health sovereignty across Africa!
Following joint guidance from Director-General @Dr_JeanKaseya and AMA Director-General Dr. Delese Mimi Darko, our core technical teams met to align on three key priorities:
1️⃣ Creating a continental quality assurance policy to guide procurement under the African Pooled Procurement Mechanism (#APPM)
2️⃣ Establishing clear procedures for prioritizing medical products for continental listing
3️⃣ Coordinating support for local manufacturers through the AMA SME & Innovation Office and the Africa CDC Business Acumen Facility
Together, we’re building a resilient, harmonized health infrastructure. This partnership marks a new chapter in advancing Africa’s health future!
#HealthSecurity
Public Alert No. 019/2026.
Alert on the mop-up of all Otrivin Nasal Drops (0.05% and 0.1%)
#NAFDACAlerts
https://t.co/2qGTWZcpXD
Counterfeit Otrivin (Children) ⬇️
With the launch of the NAFDAC Call Centre, you can report issues, make enquiries, or get verified information on regulated products and services.
📞 Complaints: 0800-1-NAFDAC (0800-1-623322)
📞 Enquiries: 0700-1-NAFDAC (0700-1-623322)
Call. Speak. Resolve. Your voice helps us protect public health and ensure safer products for all Nigerians.
On today's #ConsumerSafetyThursday, here are two things to look out for on the label of your cooking oil.
Per NAFDAC regulation on fats, oils, and foods containing fats and oils;
✅Trans-fatty acid (TFA or trans-fat) content should not be more than https://t.co/4n0JX6VGV2